Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Albany Molecular Research Inc (NASDAQ:AMRI)

15.05
Delayed Data
As of Apr 29
 -0.37 / -2.40%
Today’s Change
13.71
Today|||52-Week Range
22.48
-24.18%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Revenue and IncomeNet Revenues81.8M89.5M104.6M126.4M
 
 
 
 
 
Cost of Goods Sold52.7M58.4M73.3M84.1M
 
 
 
 
 
Depreciation And Amortization5.5M6.3M6.9M8.4M
 
 
 
 
 
 
Operating ExpensesGross Income23.7M24.9M24.4M33.9M
 
 
 
 
 
General Expenses17.4M17.1M23.1M24.9M
 
 
 
 
 
Research And Development490.0K384.0K1.9M2.7M
 
 
 
 
 
Total Operating Expenses75.5M81.7M103.3M117.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income6.3M7.8M1.3M9.0M
 
 
 
 
 
Extraordinary Charge-5.1M-1.6M-1.2M-2.8M
 
 
 
 
 
Interest Expense On Debt3.0M3.2M6.3M6.8M
 
 
 
 
 
Other Expenses469.0K634.0K798.0K319.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.3M3.6M-5.5M-245.0K
 
 
 
 
 
Income Taxes-885.0K-1.3M-1.3M-2.0M
 
 
 
 
 
Net Income-2.2M2.3M-4.2M1.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS32.8M32.1M34.1M35.6M
 
 
 
 
 
Shares To Calculate EPS Diluted32.8M33.2M34.1M35.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.07$0.07-$0.12$0.05
 
 
 
 
 
EPS Diluted-$0.07$0.07-$0.12$0.05